Vivos Therapeutics, Inc. (VVOS)

NCM – Real Time Price. Currency in USD

0.28

-0.03 (-10.20%)

Market open: Aug 12, 2026, 2:31 PM EDT

0.30

-0.01 (-4.13%)

Previous after-hours: Aug 11, 2026, 7:56 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

17M

15M

14M

16M

Cost of goods sold

-8M

-7M

-6M

-7M

Gross Profit

Operating expenses (excl. COGS)

-29M

-20M

-25M

-34M

Operating Income

-20M

-11M

-17M

-25M

Non-operating income, total

-1M

35K

Pretax income

-21M

-11M

-14M

-24M

Equity in earnings

Taxes

Non-controlling/minority interest

60K

After tax other income/expense

Net income before discontinued operations

-21M

-11M

-14M

-24M

Discontinued operations

Net income

-21M

-11M

-14M

-24M

Dilution adjustment

Preferred dividends

Vivos Therapeutics, Inc. (VVOS)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Vivos Therapeutics, Inc. (VVOS)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Vivos Therapeutics, Inc. (VVOS)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Vivos Therapeutics, Inc. (VVOS)

Income Statement (Annual)

Income Statement (Annual)